LifeMD® to Report Third Quarter 2024 Financial Results on November 7

NEW YORK, Oct. 24, 2024 (GLOBE NEWSWIRE) — LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and nine months ended September 30, 2024 after the close of the U.S. financial markets on November 7, 2024 and will host a conference call beginning at 4:30 p.m. Eastern time.

Conference Call & Webcast Details

Date: Thursday, November 7th
Time: 4:30 p.m. Eastern time
Toll-Free Dial-In: 800-717-1738
International Dial-In: 646-307-1865
Conference ID: 73461
Live & Archived Webcast: Link
   

About LifeMD, Inc.
LifeMD is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. The Company leverages a vertically-integrated, proprietary digital care platform, a 50-state affiliated medical group, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit LifeMD.com.

Investor Contact
Marc Benathen, Chief Financial Officer
marc@lifemd.com

Media Contact
Jessica Friedeman, Chief Marketing Officer
press@lifemd.com

Staff

Recent Posts

Bionic Power Secures Approximately CAD$5 Million in Series A Investment Round

Investment from strategic partners Hanger Ventures LLC and Thuasne USA and Viscogliosi Brothers Watermark will…

28 mins ago

Safe Supply Streaming Co. Ltd. Announces Non-Binding LOI to Acquire Safety Strips Tech Corp. in an All-Share Transaction and Advances Funding to Safety Strips

Toronto, Ontario--(Newsfile Corp. - October 24, 2024) - Safe Supply Streaming Co. Ltd. (CSE: SPLY)…

1 hour ago

Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024

CHATHAM, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix…

2 hours ago

Vaxart to Showcase its COVID-19 and Norovirus Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2024

SOUTH SAN FRANCISCO, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today…

2 hours ago

Legend Biotech to Host Investor Conference Call on Third Quarter 2024 Results

SOMERSET, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech),…

2 hours ago

Senseonics Holdings, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for November 7, 2024 at 4:30 P.M. Eastern Time

GERMANTOWN, Md., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a…

2 hours ago